BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2271504)

  • 1. Effects of pyrimidine salvage inhibitors on uracil incorporation of Toxoplasma gondii.
    Youn JH; Nam HW; Kim DJ; Choi WY
    Kisaengchunghak Chapchi; 1990 Jun; 28(2):79-84. PubMed ID: 2271504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase.
    Chio LC; Queener SF
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1914-23. PubMed ID: 8239605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimidine salvage in
    Elati HAA; Goerner AL; Martorelli Di Genova B; Sheiner L; de Koning HP
    Front Cell Infect Microbiol; 2023; 13():1320160. PubMed ID: 38162577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage of pyrimidine nucleosides by Trichomonas vaginalis.
    Wang CC; Cheng HW
    Mol Biochem Parasitol; 1984 Feb; 10(2):171-84. PubMed ID: 6199666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine salvage pathways in Toxoplasma gondii.
    Iltzsch MH
    J Eukaryot Microbiol; 1993; 40(1):24-8. PubMed ID: 8457800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrimidine metabolism in Tritrichomonas foetus.
    Wang CC; Verham R; Tzeng SF; Aldritt S; Cheng HW
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2564-8. PubMed ID: 6573672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidine synthesis by intracellular Toxoplasma gondii.
    Schwartzman JD; Pfefferkorn ER
    J Parasitol; 1981 Apr; 67(2):150-8. PubMed ID: 7241272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of tissue-cyst forming strain of Toxoplasma gondii and the effect of cyclic AMP and pyrimidine salvage inhibitors.
    Choi WY; Park SK; Nam HW; Kim DJ
    Korean J Parasitol; 1994 Mar; 32(1):19-26. PubMed ID: 8167104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assessment of antimicrobial agents against Toxoplasma gondii.
    Harris C; Salgo MP; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Jan; 157(1):14-22. PubMed ID: 3121760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine.
    Fox BA; Belperron AA; Bzik DJ
    Mol Biochem Parasitol; 1999 Jan; 98(1):93-103. PubMed ID: 10029312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific labeling of intracellular Toxoplasma gondii with uracil.
    Pfefferkorn ER; Pfefferkorn LC
    J Protozool; 1977 Aug; 24(3):449-53. PubMed ID: 21288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
    Karle JM; Cowan KH; Chisena CA; Cysyk RL
    Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.
    Fox BA; Bzik DJ
    Nature; 2002 Feb; 415(6874):926-9. PubMed ID: 11859373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
    Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
    Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.
    Fox BA; Bzik DJ
    Infect Immun; 2010 Sep; 78(9):3744-52. PubMed ID: 20605980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of pyrimidine nucleotide salvage pathways for DNA synthesis in skin.
    DeLapp NW; Karasek MA
    J Invest Dermatol; 1976 May; 66(5):306-12. PubMed ID: 1270839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analyses of Toxoplasma gondii dihydroorotase reveal a promising anti-parasitic target.
    Pan M; Ge CC; Niu SZ; Duan YY; Fan YM; Jin QW; Chen X; Tao JP; Huang SY
    FASEB J; 2024 Jan; 38(1):e23397. PubMed ID: 38149908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uridine as an inhibitor of thymidine utilization and DNA synthesis in L cells with impeded function of thymidylate synthetase.
    Zeuthen E; Rasmussen L
    Exp Cell Res; 1976 Mar; 98(1):57-62. PubMed ID: 1253840
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid.
    Fernandes DJ; Cranford SK
    Cancer Res; 1986 Apr; 46(4 Pt 1):1741-7. PubMed ID: 2936450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.